MBB:ARCA-iShares MBS (USD)

ETF | Intermediate Government | NYSE Arca

Last Closing

USD 92.42

Change

-0.26 (-0.28)%

Market Cap

USD 9.22B

Volume

1.71M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The investment seeks to track the investment results of the Bloomberg Barclays U.S. MBS Index. The fund seeks to track the performance of the underlying index by investing at least 90% of its assets in the securities of the underlying index and in investments that provide substantially similar exposure to securities in the underlying index. The index measures the performance of investment-grade mortgage-backed pass-through securities issued by the Federal National Mortgage Association ("Fannie Mae"), Federal Home Loan Mortgage Corporation ("Freddie Mac") and Government National Mortgage Association ("Ginnie Mae").

Inception Date: 13/03/2007

Primary Benchmark: BBgBarc US MBS TR USD

Primary Index: BBgBarc US Agg Bond TR USD

Gross Expense Ratio: 0.25%

Management Expense Ratio: 0.08 %

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Holdings

N/A

Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-03-28 )

Largest Industry Peers for Intermediate Government

Symbol Name Mer Price(Change) Market Cap
VGIT Vanguard Intermediate-Term Tre.. 0.07 %

N/A

USD 25.89B
VMBS Vanguard Mortgage-Backed Secur.. 0.07 %

N/A

USD 16.95B
IEI iShares 3-7 Year Treasury Bond.. 0.15 %

N/A

USD 13.17B
GNMA iShares GNMA Bond ETF 0.12 %

N/A

USD 0.32B

ETFs Containing MBB

ZUAG:CA BMO US Aggregate Bond Ind.. 28.41 % 0.00 %

N/A

CAD 9.70M
ZUAG-F:CA BMO US Aggregate Bond ETF.. 28.41 % 0.00 %

N/A

N/A
BNDC FlexShares Core Select Bo.. 24.23 % 0.16 %

N/A

USD 0.17B
ADFI 18.75 % 0.00 %

N/A

N/A
CGBI:CA CIBC Global Bond ex-Canad.. 15.81 % 0.00 %

N/A

CAD 0.41B
IRTR Ishares Lifepath Retireme.. 14.62 % 0.00 %

N/A

USD 3.32M
ITDA Ishares Lifepath Target D.. 14.09 % 0.00 %

N/A

USD 2.79M
HOM 14.06 % 0.00 %

N/A

N/A
SAVN 13.49 % 0.00 %

N/A

N/A
ITDB Ishares Lifepath Target D.. 10.80 % 0.00 %

N/A

USD 7.36M
BYLD iShares Yield Optimized B.. 9.95 % 0.00 %

N/A

USD 0.17B
ITDC Ishares Lifepath Target D.. 9.09 % 0.00 %

N/A

USD 8.58M
FTRB Federated Hermes ETF Trus.. 8.08 % 0.00 %

N/A

USD 0.03B
WLTH 6.14 % 0.00 %

N/A

N/A
ITDD Ishares Lifepath Target D.. 5.88 % 0.00 %

N/A

USD 5.62M
ITDE Ishares Lifepath Target D.. 3.32 % 0.00 %

N/A

USD 6.42M
AGGE 0.00 % 0.21 %

N/A

N/A
AGGP 0.00 % 0.21 %

N/A

N/A
WBAL 0.00 % 0.03 %

N/A

N/A
VEGA AdvisorShares STAR Global.. 0.00 % 1.85 %

N/A

USD 0.06B
XSE:CA iShares Conservative Stra.. 0.00 % 0.56 %

N/A

CAD 0.13B
QMA:CA 0.00 % 0.80 %

N/A

N/A
ONEC:CA Accelerate OneChoice Alte.. 0.00 % 0.00 %

N/A

CAD 0.02B

Market Performance

  Market Performance vs. Industry/Classification (Intermediate Government) Market Performance vs. Exchange (NYSE Arca)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -1.76% 40% F 42% F
Dividend Return 0.63% 80% B- 41% F
Total Return -1.14% 40% F 43% F
Trailing 12 Months  
Capital Gain -2.16% 20% F 45% F
Dividend Return 2.91% 60% D- 45% F
Total Return 0.75% 20% F 46% F
Trailing 5 Years  
Capital Gain -13.11% 20% F 42% F
Dividend Return 8.87% 60% D- 35% F
Total Return -4.23% 20% F 42% F
Average Annual (5 Year Horizon)  
Capital Gain -3.72% 20% F 37% F
Dividend Return -2.03% 20% F 37% F
Total Return 1.69% 80% B- 42% F
Risk Return Profile  
Volatility (Standard Deviation) 5.25% 60% D- 91% A-
Risk Adjusted Return -38.74% 40% F 24% F
Market Capitalization 9.22B 100% F 97% N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Underpriced on free cash flow basis

The stock is trading low compared to its peers on a price to free cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

Poor return on equity

The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.